|
Electromagnetic Treatment For Bone Loss After Forearm Fracture Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Electromagnetic Treatment For Bone Loss After Forearm Fracture conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Electromagnetic Treatment For Bone Loss After Forearm Fracture Clinical research trials and Electromagnetic Treatment For Bone Loss After Forearm Fracture healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Electromagnetic Treatment For Bone Loss After Forearm Fracture. Electromagnetic Treatment For Bone Loss After Forearm Fracture Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Electromagnetic Treatment For Bone Loss After Forearm Fracture clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Electromagnetic Treatment For Bone Loss After Forearm Fracture condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Electromagnetic Treatment For Bone Loss After Forearm Fracture  Electromagnetic Treatment For Bone Loss After Forearm Fracture
Electromagnetic Treatment For Bone Loss After Forearm Fracture
For Condition: Bone Disease, Metabolic,Osteoporosis, Post-Traumatic,Osteopenia
Status: Recruiting
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,
Synopsis: This study will determine the usefulness of pulsing electromagnetic field (PEMF) technology to reverse or reduce the bone loss (osteopenia) that occurs in the forearm after fracture or surgery.
Details: The long-range goal of this research is to develop a new and supplementary local treatment for osteoporosis to reduce the risk of fracture in susceptible individuals. PEMF is a noninvasive method to magnetically introduce a small amount of electrical current to a specific bone region to stimulate bone formation. PEMFs have been used for many years to treat nonunited fractures and enhance spine fusion healing and have been found to improve bone density in animal models of osteoporosis. Such a noninvasive intervention applied to the hip or spine, which are especially associated with high morbidity and mortality in aging individuals, could have a significant national health care impact. If effective for the treatment of bone loss, PEMF technology may be effective in treating osteoporosis. The primary objective of this pilot study is to determine the feasibility of using PEMFs to reverse or reduce bone loss that occurs with disuse of the forearm after fracture or surgery and to determine the effect of daily treatment duration on efficacy. Eighty patients who have recently undergone immobilization after hand surgery or after lower forearm fracture will be enrolled in this study. Participants will be randomized to either the PEMF group or a control group. PEMFs will be administered by means of a magnetic coil transducer placed over the treatment site for 1, 2, or 4 hrs/day for 8 weeks, beginning 6 weeks after the initial injury or surgery. A self-contained, battery-powered PEMF coil transducer already FDA-approved for fracture healing in the forearm will be used. Participants in the control group will receive inactive but otherwise identical units and treatment times. Measurements of bone density will be made using DEXA (dual energy x-ray absorptiometry) and pQCT (peripheral quantitative computer tomography) and compared to baseline. DEXA and pQCT provide planar and cross-sectional x-ray densitometry to determine forearm bone changes. Bone densities (global, cortical, and trabecular), bone cross-sectional structural geometry, and calculated strength index will be measured and compared to baseline values.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/80 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - Treatment and immobilization for carpal instability or repair or a lower forearm fracture (Colles' or Smith's) within 6 weeks - Intact, normal prior skeletal anatomy and function in both arms Exclusion Criteria - Previous forearm fracture (either arm), orthopedic procedure, or forearm deformity which might affect forearm bone density - History of renal disease, liver disease, diabetes, hyperthyroidism, hyperparathyroidism, Cushing’s disease, uncontrolled seizures, rheumatoid arthritis, Paget’s disease, multiple myeloma, or hypothyroidism - Implanted cardiac pacemakers or defibrillators - Pregnant - Drug therapies within the previous 3 months that could affect bone (e.g., bisphosphonates, estrogen, progesterone, CaF2, calcitonin, steroids, anti-seizure medications) - Difficulties complying with the protocol due to physical or mental inability, drug or alcohol abuse, psychosis or dementia, imprisonment, or unavailable for follow-up - History of osteoporosis, as defined by a DEXA T-score of more than 2 standard deviations below normal in the hip, spine, or unaffected forearm - Prior osteoporotic hip or vertebral fracture
Total Enrollment: 80
Location and Contact Information:
Overall Study Official:
JosephSpadaro, Principal Investigator, Upstate Medical University Orthopedic Research Lab
Upstate Medical University Orthopedic Research Lab *Recruiting*
Syracuse, New York, 13210
United States
Recruiting Joseph Spadaro 315-464-6625
Additional Information:
Study ID Numbers: NIAMS-091; N01-AR-3-2267
Study Start Date: November 2003
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00067834
Other Osteopenia Studies:
1. Electromagnetic Treatment For Bone Loss After Forearm Fracture
2. Adding Phosphorus to Osteoporosis Drug Treatment
3. Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
4. Encouraging Calcium Absorption and Bone Formation During Early Puberty
5. Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients with Gaucher's Disease
Related Studies:
Other Osteopenia Clinical Trials
Other New York Clinical Trials
Other Syracuse Clinical Trials
Electromagnetic Treatment For Bone Loss After Forearm Fracture
|
|
|
|
|
|
|
|
